[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI914275A0 - Bensimidazolderivat, framstaellning och anvaendning av dessa. - Google Patents

Bensimidazolderivat, framstaellning och anvaendning av dessa.

Info

Publication number
FI914275A0
FI914275A0 FI914275A FI914275A FI914275A0 FI 914275 A0 FI914275 A0 FI 914275A0 FI 914275 A FI914275 A FI 914275A FI 914275 A FI914275 A FI 914275A FI 914275 A0 FI914275 A0 FI 914275A0
Authority
FI
Finland
Prior art keywords
hydrogen
bensimidazolderivat
dessa
halogen
alkyl
Prior art date
Application number
FI914275A
Other languages
English (en)
Other versions
FI914275A (fi
FI103408B1 (fi
FI103408B (fi
Inventor
Soeren-Peter Olesen
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of FI914275A0 publication Critical patent/FI914275A0/fi
Publication of FI914275A publication Critical patent/FI914275A/fi
Application granted granted Critical
Publication of FI103408B1 publication Critical patent/FI103408B1/fi
Publication of FI103408B publication Critical patent/FI103408B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Graft Or Block Polymers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI914275A 1990-09-24 1991-09-11 Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaiste n valmistamiseksi FI103408B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58690090A 1990-09-24 1990-09-24
US58690090 1990-09-24

Publications (4)

Publication Number Publication Date
FI914275A0 true FI914275A0 (fi) 1991-09-11
FI914275A FI914275A (fi) 1992-03-25
FI103408B1 FI103408B1 (fi) 1999-06-30
FI103408B FI103408B (fi) 1999-06-30

Family

ID=24347548

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914275A FI103408B (fi) 1990-09-24 1991-09-11 Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaiste n valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0477819B1 (fi)
JP (1) JP3203017B2 (fi)
KR (1) KR100195770B1 (fi)
AT (1) ATE119887T1 (fi)
AU (1) AU635440B2 (fi)
CA (1) CA2052041C (fi)
DE (1) DE69108156T2 (fi)
DK (1) DK0477819T3 (fi)
ES (1) ES2072504T3 (fi)
FI (1) FI103408B (fi)
IE (1) IE67133B1 (fi)
NO (1) NO180795C (fi)
NZ (1) NZ239540A (fi)
PT (1) PT99032B (fi)
ZA (1) ZA916805B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0520200T3 (da) * 1991-06-24 1998-09-23 Neurosearch As Imadazol-forbindelser, deres fremstilling og anvendelse
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
US5232899A (en) * 1992-06-08 1993-08-03 Imperial Chemical Industries Plc Benzoxazolinones and their use as herbicides
AU5433594A (en) * 1992-11-19 1994-06-08 Dainippon Pharmaceutical Co. Ltd. 3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
DK28893D0 (da) * 1993-03-15 1993-03-15 Neurosearch As Benzimidazole derivater, deres fremstilling og anvendelse
DK41193D0 (da) * 1993-04-07 1993-04-07 Neurosearch As Ionkanalaabnere
US5637470A (en) * 1994-05-13 1997-06-10 Merck & Co., Inc. Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5565483A (en) * 1995-06-07 1996-10-15 Bristol-Myers Squibb Company 3-substituted oxindole derivatives as potassium channel modulators
TW504504B (en) * 1996-11-26 2002-10-01 Bristol Myers Squibb Co 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
US5893085A (en) * 1997-06-10 1999-04-06 Phillips; Ronald W. Dynamic fuzzy logic process for identifying objects in three-dimensional data
CA2301549A1 (en) * 1997-08-28 1999-03-04 Piyasena Hewawasam 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
EP1144387A1 (en) * 1998-12-04 2001-10-17 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
PT1133474E (pt) * 1998-12-04 2007-04-30 Bristol Myers Squibb Co Derivados da 4-arilquinolin-2-ona substituidos em 3 posições utilizados como moduladores do canal de potássio.
EP1519923A1 (en) * 2002-06-26 2005-04-06 Poseidon Pharmaceuticals A/S Novel benzimidazol-2-one derivatives and their use
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
ES2222831B2 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de principio activo que comprende un compuesto 2,5-dihidroxibencenosulfonico y un modulador de los canales de k+.
PE20060572A1 (es) * 2004-07-27 2006-06-27 Novartis Ag Compuestos de benzoimidazolona como inhibidores de hsp90
CA2680769C (en) * 2007-04-18 2015-10-13 Kissei Pharmaceutical Co., Ltd. Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH460028A (de) * 1965-01-22 1968-07-31 Wander Ag Dr A Verfahren zur Herstellung von Benzimidazolonderivaten
FR1561830A (fi) * 1968-05-08 1969-03-28
GB1408408A (en) * 1971-11-24 1975-10-01 Beecham Group Ltd Benzimidazole derivatives
GB1476949A (en) * 1974-11-20 1977-06-16 Wyeth John & Brother Ltd Imidazo-1,2-a-benzimidazole and pyrimido-1,2-a-benzimidazole derivatives their preparation and their pharmaceutical compositions
CH622009A5 (fi) * 1976-06-11 1981-03-13 Ciba Geigy Ag
DE3042481A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
EG17993A (en) * 1986-02-03 1991-08-30 Janssen Pharmaceutica Nv Anti-histaminic compositions containing n-heterocyclyl-4-piperidinanines

Also Published As

Publication number Publication date
ES2072504T3 (es) 1995-07-16
EP0477819A3 (en) 1992-05-20
EP0477819B1 (en) 1995-03-15
EP0477819A2 (en) 1992-04-01
IE913197A1 (en) 1992-02-25
FI914275A (fi) 1992-03-25
JPH04305568A (ja) 1992-10-28
NZ239540A (en) 1993-11-25
NO913728D0 (no) 1991-09-23
PT99032A (pt) 1993-11-30
JP3203017B2 (ja) 2001-08-27
ZA916805B (en) 1992-05-27
IE67133B1 (en) 1996-03-06
AU8276791A (en) 1992-03-26
KR920006327A (ko) 1992-04-27
NO913728L (no) 1992-03-25
FI103408B1 (fi) 1999-06-30
KR100195770B1 (ko) 1999-06-15
DE69108156T2 (de) 1995-07-06
CA2052041C (en) 2002-08-20
FI103408B (fi) 1999-06-30
AU635440B2 (en) 1993-03-18
ATE119887T1 (de) 1995-04-15
CA2052041A1 (en) 1992-03-25
DE69108156D1 (de) 1995-04-20
PT99032B (pt) 1999-02-26
NO180795B (no) 1997-03-17
DK0477819T3 (da) 1995-07-17
NO180795C (no) 1997-06-25

Similar Documents

Publication Publication Date Title
FI914275A0 (fi) Bensimidazolderivat, framstaellning och anvaendning av dessa.
TR199901674T2 (fi)
ES484059A1 (es) Procedimiento para proteger materiales queratinicos contra el ataque de insectos devoradores de queratina
ATE88699T1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
FI831388L (fi) 2-/2'-hydroxi-3'-(1,1-dimetylpropylamino)-propoxi/- -fenylpropionfenon, syreadditionssalter av denna foerfarande foer framstaellning av denna och farmaceutiska sammansaettningar
FI905943A0 (fi) Isotinderivat, deras framstaellning och anvaendning.
DE69017511D1 (de) Butenoinsäure-Derivate.
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
FI941214A (fi) Bentsimidatsolin johdannaisia, niiden valmistus ja käyttö
DE69515402D1 (de) Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
PT78155A (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung
FI871407A (fi) Anvaendning av substituerade n-triklormetyltiohydantoiner i kombination med bis-(2,4-diamino-2 -triazin-6-yl)-oligosulfider i vulkaniserbara kautschukblandningar, och dylika kautschukblandningar.
SE7910612L (sv) Metod att kontrollera hypertension och intestinala sjukdomar samt kompositioner
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
JPS545995A (en) Thiazoropyrimidine compounds and herbicides containing the same as active constituents
ATE114307T1 (de) Phenylglycidamide, verwendbar in der herstellung von alpha-hydroxy-beta-sulfido-arylpropionsäure- derivaten.
JPS53127444A (en) Oxime substd. phenylacetic acid derivtives and their preparation
FR2383186A1 (fr) Nouveaux esters d'acide a-(4-(benzyloxy)phenyl)-(7-oxo-3-phenyl-4-oxa-2,6-diazabicyclo (3.2.0)-hept-2-en-6)-acetique et leur preparation
JPS5548252A (en) Oxidative color developing dyestuff for keratin fiber
JPS53119825A (en) 1,3-dithioallophanate derivatives, their preparation, insecticides, acaricides, and bactericides for agricultural and horticultural uses
ATE56004T1 (de) Triazinderivat, seine herstellung und verwendung.

Legal Events

Date Code Title Description
MA Patent expired